Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Florbetapir PET for Prediction of Postoperative Cognitive Decline
NCT01606488Phase 4Active, not recruiting
- Sponsor
- University of California, San Francisco
- Start
- May 2012
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Florbetapir in Post-operative cognitive dysfunction (POCD), sponsored by University of California, San Francisco. Started May 2012; status: active, not recruiting.
02
Drugs
Florbetapir
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT01606488.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01606488.